Voyager Therapeutics Statistics
Total Valuation
BMV:VYGR has a market cap or net worth of MXN 3.42 billion. The enterprise value is -1.51 billion.
Market Cap | 3.42B |
Enterprise Value | -1.51B |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 55.34M |
Shares Outstanding | n/a |
Shares Change (YoY) | +22.98% |
Shares Change (QoQ) | +0.65% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 45.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.50 |
PB Ratio | 0.61 |
P/TBV Ratio | 0.61 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.87 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 0.65 |
Financial Position
The company has a current ratio of 6.10, with a Debt / Equity ratio of 0.15.
Current Ratio | 6.10 |
Quick Ratio | 5.92 |
Debt / Equity | 0.15 |
Debt / EBITDA | n/a |
Debt / FCF | -0.37 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.61% and return on invested capital (ROIC) is -17.59%.
Return on Equity (ROE) | -27.61% |
Return on Assets (ROA) | -15.04% |
Return on Invested Capital (ROIC) | -17.59% |
Return on Capital Employed (ROCE) | -31.63% |
Revenue Per Employee | 7.96M |
Profits Per Employee | -10.06M |
Employee Count | 172 |
Asset Turnover | 0.16 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.00% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -60.00% |
50-Day Moving Average | 124.23 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 29.23 |
Average Volume (20 Days) | 908 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 7.68 |
Income Statement
In the last 12 months, BMV:VYGR had revenue of MXN 1.37 billion and -1.73 billion in losses. Loss per share was -29.86.
Revenue | 1.37B |
Gross Profit | -1.27B |
Operating Income | -2.02B |
Pretax Income | -1.72B |
Net Income | -1.73B |
EBITDA | -1.93B |
EBIT | -2.02B |
Loss Per Share | -29.86 |
Balance Sheet
The company has 4.82 billion in cash and 858.35 million in debt, giving a net cash position of 5.17 billion.
Cash & Cash Equivalents | 4.82B |
Total Debt | 858.35M |
Net Cash | 5.17B |
Net Cash Per Share | n/a |
Equity (Book Value) | 5.57B |
Book Value Per Share | 100.96 |
Working Capital | 4.19B |
Cash Flow
In the last 12 months, operating cash flow was -2.29 billion and capital expenditures -41.65 million, giving a free cash flow of -2.33 billion.
Operating Cash Flow | -2.29B |
Capital Expenditures | -41.65M |
Free Cash Flow | -2.33B |
FCF Per Share | n/a |
Margins
Gross margin is -92.70%, with operating and profit margins of -147.89% and -126.49%.
Gross Margin | -92.70% |
Operating Margin | -147.89% |
Pretax Margin | -125.46% |
Profit Margin | -126.49% |
EBITDA Margin | -141.09% |
EBIT Margin | -147.89% |
FCF Margin | n/a |
Dividends & Yields
BMV:VYGR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.98% |
Shareholder Yield | -22.98% |
Earnings Yield | -50.64% |
FCF Yield | -68.17% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BMV:VYGR has an Altman Z-Score of 1.27. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.27 |
Piotroski F-Score | n/a |